Serum amyloid A—A potential therapeutic target for hyper-inflammatory syndrome associated with COVID-19

Serum amyloid A—A potential therapeutic target for hyper-inflammatory syndrome associated with COVID-19

Serum amyloid-A (SAA) is associated with inflammatory disorders such as rheumatoid arthritis, Familial Mediterranean Fever, sarcoidosis, and vasculitis. There is accumulating evidence that SAA is a reliable biomarker for these autoinflammatory and rheumatic diseases and may contribute to their patho...

Full description

Bibliographic Details
Main Authors: Eman M. Almusalami, Anthony Lockett, Albert Ferro, John Posner
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Medicine
Subjects:
serum amyloid A
target
hyperinflammation
COVID-19
inflammation
cytokines
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1135695/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1135695/full

Similar Items